Botanical

Bacopa monnieri

Also called bacopa, brahmi, water hyssop, bacosides

By Kymata Labs EditorialMedical review pendingLast reviewed October 11, 2026 · What changed

Kymata Health may earn a commission from the partner product links in the Where to buy section, marked where they appear. Educational reference, not medical advice.

Summary

Bacopa is an Ayurvedic herb. A pooled analysis of 9 trials (518 people) found faster attention and reaction time after at least 12 weeks (grade C), and a trial in adults 65+ found better delayed word recall. A 2025 trial of 101 middle-aged adults found no memory benefit. Benefits appeared only after weeks of use.

Top graded outcomes:C evidence grade Attention speed and reaction timeC evidence grade Delayed word recall and attention in older adults

Key facts

What it is
An Ayurvedic herb; extracts are standardised to bacosides (often 20–55%)[1]
Best-studied outcome
Speed of attention and choice reaction time after ≥12 weeks (9 RCTs, 518 people; grade C)[1]
Studied doses
300 mg/day of standardised extract in most trials[2][3]
Mixed results
A 2025 12-week trial found no between-group change in verbal learning or other primary outcomes[3]
Evidence base
3 graded human outcomes on this page
Last reviewed
October 11, 2026

How it works

ProposedBacosides are proposed to support cholinergic signalling and antioxidant defences in the brain, based mainly on animal studies.[1]

What the human research says

Human trials only, one row per outcome. The form column shows what each trial actually tested. Grades follow our evidence-grading policy.

Grade
Form tested
Sort

Showing 3 of 3 outcomes. Human trials only.

OutcomeEffectGradeBest evidencePMID
Attention speed and reaction timeImprovedGrade C

Meta-analysis · n = 518 · 2014

Adults in 9 RCTs of standardised extracts for ≥12 weeks

Form: Standardised Bacopa monnieri extract · Dose: Varied across trials · Duration: 12 weeks or longer

Cognition improved versus placebo, particularly speed of attention and choice reaction time.

24252493 (opens PubMed)Source [1]
Delayed word recall and attention in older adultsImprovedGrade C

RCT · n = 54 · 2008

Adults 65+ without dementia

Form: Standardised Bacopa monnieri extract · Dose: 300 mg/day · Duration: 12 weeks

Delayed word recall and Stroop scores improved versus placebo; depression and anxiety scores fell.

18611150 (opens PubMed)Source [2]
Verbal learning and memory in midlifeNo effectNo effect

RCT · n = 101 · 2025

Adults aged 40–70 with self-reported memory and attention problems

Form: Bacopa monnieri extract (Bacumen) · Dose: 300 mg/day · Duration: 12 weeks

No between-group differences in the primary cognitive outcomes.

41091332 (opens PubMed)Source [3]

Forms

FormElemental %Absorption (human data)GI toleranceStudied for
Standardised extract (bacosides)VariesNot applicable (whole compound or extract; no elemental fraction)No head-to-head human absorption data between extracts in the sources cited here.Generally tolerated in the 12-week trials cited here.[2]All cognition trials cited here

Studied doses

Doses studied in human trials ranged from 300 mg/day of standardised extract for 12 weeks (the older-adult and midlife trials cited here) to other standardised doses in the pooled analysis, all for at least 12 weeks.[2][3]

These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.

Interactions

Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.

None found in our sources.

Who should be careful

Pregnancy and breastfeeding
The trials cited here did not enrol pregnant or breastfeeding people.[1]

Talk to your pharmacist or clinician before starting a supplement, especially if you take prescription medicines.

Where to buy Bacopa monnieri

Products from brands we partner with that contain Bacopa monnieri. Listing a product is not a claim that it works; check the amount per serving against the doses studied above, and the label for other ingredients.

  • SupersmartPaid linkBacopa Monnieri6 capsules: 1,500 mg leaf extract standardised to 20% bacosides (250 mg per capsule), well above the 300 mg/day used in the trials above; 16 servingsShop at Supersmart (opens in new tab)Price and label checked 2026-10-11 on the brand’s site.

    Partner links may earn us a commission. Learn more

    One-time
    $21
    Subscription
    $17.85

    15% off with code SMART026

    Enter code SMART026 at checkout on us.supersmart.com.

    Code SMART026

    Get 15% off with SMART026 (opens in new tab)

    Partner links may earn us a commission. Learn more

    • Supersmart’s own terms and exclusions apply at checkout.
    • 20% applies when 3 or more products ship on auto-delivery to the same address.
    • The code discount and Subscribe & Save are separate offers; we don’t claim they combine.
    • Offer terms from Supersmart’s site and its affiliate program, checked Oct 8, 2026. Offers can change; the brand's checkout is final.

Frequently asked questions

How long does bacopa take to work?

The pooled analysis included only trials of 12 weeks or longer; benefits were measured after that time.[1]

Does bacopa improve memory?

Results are mixed: some trials found better recall, while a 2025 trial found no difference from placebo.[2][3]

What dose was used in trials?

Most trials cited here used 300 mg/day of a standardised extract.[2][3]

Is bacopa the same as brahmi?

Brahmi is a common Ayurvedic name for Bacopa monnieri, though the name is sometimes also used for gotu kola.

Sources

  1. [1]Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.. J Ethnopharmacol, 2014. meta-analysis PMID 24252493
  2. [2]Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.. J Altern Complement Med, 2008. RCT PMID 18611150
  3. [3]The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.. Clin Drug Investig, 2025. RCT PMID 41091332

What changed

  1. October 11, 2026 · all · new page (encyclopedia expansion, A–L)First draft. Every PMID checked against NCBI E-utilities (title, journal and year taken from the PubMed record) and each evidence row written from its PubMed abstract.Writer: Kymata Labs Editorial · No credentialed reviewer yet

How we write, grade and correct these pages: editorial and evidence policy.

Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.

Supplements and vitamins: every page →Supplement & Nutrient Encyclopedia →Browse all topics →

Evidence-graded supplement stacks →